Aquinox Pharma Nabs $25M

Xconomy Seattle — 

Aquinox Pharmaceuticals, a Vancouver, BC-based developer of small molecule drugs for cancer and inflammatory diseases, said today it has secured a $25 million second round of venture financing. The deal was led by Ventures West, and included Pfizer Venture Investments, Johnson & Johnson Development Corporation, Baker Brothers Investments and BC Advantage Funds. The money will be used to help Aquinox advance its lead drug candidate into early and mid stage clinical trials against a target called SHIP1.